retatrutide triple agonist obesity phase 2 trial glp-1 gip glucagon results Retatrutide, a GIP, and receptor agonist retatrutide phase 2 trial obesity
Pay in 4 interest-free payments of $6.54 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6



























